Latest news
Axovant in-licences gene therapies from UMass
Axovant Sciences has licensed exclusive worldwide rights for the development and commercialisation of two novel gene therapy programs to address GM1 gangliosidosis and GM2...
European approval for self-administration of Novartis’ Xolair
Novartis has this week secured approval in Europe for Xolair prefilled syringe for self-administration.
The treatment allows patients with severe allergic asthma (SAA) and chronic...
Bausch Health acquiring beleaguered Synergy out of bankruptcy
Bausch Health Companies has acquired biopharma Synergy Pharmaceuticals out of bankruptcy for $200 million.
News of the acquisition comes as the beleaguered company filed a...
